Companies: 10,795·Total market cap: $144.5T
Gamida Cell Ltd.

Gamida Cell Ltd.

GMDANASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$4337295
P/E Ratio
52W High$0.0395
52W Low$0.0327

Gamida Cell Ltd. (GMDA) Revenue

Annual & quarterly revenue history · segment & region breakdown

GMDA · revenue · updated Jun 9, 2026

Core revenue metrics

Gamida Cell Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
143 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Gamida Cell Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GMDA revenue by year · GMDA revenue history · GMDA annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Gamida Cell Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Gamida Cell Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Gamida Cell Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GMDA revenue · 4 questions

GMDA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

GMDA revenueGMDA annual revenuewhat is GMDA revenueGMDA TTM revenue

Source: FMP · Gamida Cell Ltd. SEC filings · GAAP · Gamida Cell Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026